AI Science Tracker
EN

Bioinformatics analyses associated ANXA1 with head-and-neck cancer progression and chemotherapy resistance

Southwest Medical University; Affiliated Hospital of Southwest Medical University · 26 Feb 2026 · biology

Discovery

Bioinformatics analyses associated ANXA1 with head-and-neck cancer progression and chemotherapy resistance

Source check: Source checked. Not independent scientific confirmation.

Finding: Machine-learning analysis of tumor-expression datasets identified ANXA1-related prognostic and chemotherapy-resistance signals in head-and-neck squamous-cell carcinoma. The paper also reports cell-based experiments; computational associations and candidate-compound analyses do not establish therapeutic efficacy.

Technology: LASSO-Cox modeling of tumor datasets with AI-based virtual-cell and molecular-docking analyses.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
LASSO-Cox modeling of tumor datasets with AI-based virtual-cell and molecular-docking analyses.
Test and result
Analyses used TCGA/GEO datasets with validation in GSE65858; cell experiments examined ANXA1-related effects. A candidate compound was computationally proposed.
Limitation / still unknown
Retrospective bioinformatics plus in-vitro experiments; no clinical treatment efficacy or prospective patient validation established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12979454/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse biology discoveries.